KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Calumet (CLMT) Cash & Equivalents (2022 - 2025)

Calumet (CLMT) has disclosed Cash & Equivalents for 4 consecutive years, with $125.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 228.35% to $125.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $125.1 million, a 228.35% increase, with the full-year FY2025 number at $125.1 million, up 228.35% from a year prior.
  • Cash & Equivalents was $125.1 million for Q4 2025 at Calumet, up from $94.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $125.1 million in Q4 2025 to a low of $7.0 million in Q2 2024.
  • A 4-year average of $54.2 million and a median of $35.6 million in 2022 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: crashed 80.56% in 2024, then skyrocketed 1480.0% in 2025.
  • Calumet's Cash & Equivalents stood at $35.2 million in 2022, then crashed by 77.56% to $7.9 million in 2023, then surged by 382.28% to $38.1 million in 2024, then soared by 228.35% to $125.1 million in 2025.
  • Per Business Quant, the three most recent readings for CLMT's Cash & Equivalents are $125.1 million (Q4 2025), $94.6 million (Q3 2025), and $110.6 million (Q2 2025).